ALVARO PADILLA, MD

apadilla@smgumc.com

General neurologist with a special interest in traumatic brain injury, acute and chronic back pain, headache and stroke disorders.

PROFESSIONAL and TEACHING ACTIVITIES

[2006-present] Sunrise Medical Group, Hollywood, Florida

[2006-present] Sunrise Clinical Research, Hollywood, Florida

[2001-2002] Director of Cardiovascular Program. School for Technologist, Miami, FL

[1998-2001] Emergency Physician, Mexico Hospital, Costa Rica

MEDICAL DEGREE

[1992-1998] Autonomous University of Central America, San Jose, Costa Rica

CERTIFICATIONS, QUALIFICATIONS AND APPOINTMENTS

Educational Commission for Foreign Medical Graduates

[2006] Florida ME License

Medical Director of the Memorial Regional Hospital Stroke Program, Broward County, FL

American Board of Psychiatry and Neurology, eligble

GRADUATE TRAINING

Internship: Internal Medicine

[2002-2003] (Mercy Health System with MCP Hanneman, Philadelphia, PA)

Residency: Neurology

[2003-2006] (Cleveland Clinic Foundation, Weston, FL.)

AFFILIATED ASSOCIATIONS

American Academy of Neurology

ACLS

BLS Trainer

American Stroke Association

RESEARCH, PRESENTATIONS, PUBLISHED BOOKS AND PAPERS

[Oct 2005] Florida Spine Symposium, Medical Work Up of Acute and Chronic Back Pain

[Mar 2006] Grand Rounds, Cleveland Clinic, Traumatic Brain Injury, CME Conference, MRH

[Oct 2006] Path physiology and Management of Intracranial Hemorrhage

[Sep 2005] M and M, Cleveland Clinic, Case of Hemangiopericytoma

“A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 of More Headache Days per 4-Week Period in a 24-Week, Double Blind, Randomized, Placebo-Controlled Parallel-Group Followed by a 32-Week Open-Label Extension”

“Retrospective Randomized investigation to Evaluate incidence of headache reduction in subjects with migraine and PFO using the AMPLATZER PFO Occiuder compared to Medical Management”

“A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 2 Study

Designed to Assess the Efficacy and Safety of X) OOCXX in Subjects with Painful Diabetic Neuropathy”

“A Prospective, Multi-Centered Clinical Evaluation of the EON~ 16-Channel Implantable Pulse Generator (IPG) in combination with a lead tripole array for the management of chronic back pain with or without leg pain”

“Randomized Evaluation of Recurrent Stoke comparing fF0 Closure to Established Current Standard of Care Treatment”

“A Multicenter Trial Evaluating the Efficacy of Cesamet~ for the Symptomatic Treatment of Pain in Patients with Multiple Sclerosis”

“A Multicenter Trial Evaluating the Efficacy of CesamctTM for the Symptomatic Treatment of Pain in Patients with Diabetic Peripheral Neuropathy”

“A Randomized, Double-Blind, Active-Control, Parallel Group, 90-Day Safety Study of XXXXXX Immediate Release or Oxycodone Immediate Release in Subjects with Chronic Pain from Low Back Pain or Osteoarthritis of the Hip or Knee Back Pain or Osteo arthritis of the Hip or Knee”

“A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of XXXXX in Levodopa Treated Parkinson’s Disease Patients with Motor Fluctuations”

“A randomized, double-blind, placebo-controlled, parallel-group clinical trial to examine the efficacy and safety of early pramipexole treatment versus delayed pramipexole treatment in patients with new onset Parkinson’s disease”

“A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of 8 Week Treatment of Rozerem 8 mg (QHS) in Sleep Disturbed, Community Dwelling, Mild to Moderately Severe Alzheimer’s Disease Subjects”

“An Open-label Exploratory Study with Memantine of Selected Measures of Volumetric MIII and Cognition in Patients with Moderate Dementia of the Alzheimer’s Type”

“Phase 3 Multinational, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment with XXX-XXXX on Measures of Cognition, Activities of Daily Living and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type”

“A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL XXX-XXX FOR THE TREATMENT OF OPEIOD­INDUCED BOWEL DYSFUNCTION IN SUBJECTS WITH CHRONIC NON-MALIGNANT PAIN”